INTRODUCTION 46
While there has been rapid recent progress in understanding the ontogeny of myeloid 47 cells, including monocytes, macrophages, dendritic cells and granulocytes in recent years, the 48 heterogeneity of activation states between these different cell types remains poorly understood. 49
Single cell RNA seq technologies of inflamed tissues has begun to provide an appreciation for 50 the heterogeneity of activation states for different myeloid cells, however these cells typically 51 encounter a complex mixture of cytokines in their tissue microenvironment. The overall status 52 of immune cells in a particular tissue or in blood circulation in disease conditions is an important 53 indicator of disease state. Transcriptional profiles of immune cells have thus been used to define 54 gene expression signatures that could potentially guide personalized clinical decision-making 55 through patient stratification and evaluation of disease-associated gene expression changes. 56
However, in most cases, transcriptional profiles are generated from bulk tissues or whole blood, 57 masking changes in the transcriptomic composition of specific cell types. Recently, 58 computational approaches have been developed to infer leukocyte compositions in bulk tissue 59 transcriptomes based on cell-type specific reference gene expression signatures (1) . One such 60 study found that the ratio of tumor-associated neutrophils and plasma cell signatures was 61 predictive of survival for various solid tumors (2). While this strategy enables the deconvolution 62 of immune cell types infiltrating different tissues, the environmental conditions they encounter as 63 they infiltrate the tissues is not yet known. 64
Identifying specific transcriptional programs in myeloid cells may facilitate the discovery 65 of biomarkers and targets for therapies for a variety of diseases. Both granulocytic myeloid cells 66 (e.g. neutrophils, eosinophils and basophils) and monocytic myeloid cells are important innate 67 immune components of the inflammatory infiltrate, being almost universally present in any 68 disease condition. They are all critical not just for protection against pathogens but also for tissue 69 remodeling and maintenance of tissue homeostasis. The same differentiation processes that guide 70 the physiologically necessary function of these cells are also responsible for the pathological 71 accumulation of these cells under certain inflammatory conditions. For example, myeloid 72 derived suppressor cells (MDSCs) can play pathological roles in cancer, as well as other 73 inflammatory settings where they accumulate and differentiate (3). 74
The cytokine environment is a critical determinant of immune cell activation phenotypes 75 and the response of diverse immune cells to the different cytokines is not well understood. 76
Further, cell types respond differentially to various cytokine stimulation conditions to express 77 distinct transcriptional signatures. This may be due to differences in chromatin state and cytokine 78 receptor expression levels that determine, for example, how macrophages and dendritic cells 79 respond to IL-10 stimulation as compared to IFN-γ stimulation (4, 5). While there have been 80 experimental studies whereby transcriptional response has been assessed in specific immune cell 81 types following exposure to assorted cytokines, we are not aware of a systematic comparison of 82 diverse myeloid cell types in response to a wide variety of different cytokine stimulation 83 conditions. Here, we compare the transcriptional response of primary human macrophages, 84 dendritic cells, monocytes and neutrophils to stimulation with a cytokine panel consisting of IL-85 4, IL-10, IL-13, IFN-γ, IFN-β, and IFN-. These signatures were then used to infer the signature 86 of specific immune cell types responding to specific cytokine environments from bulk 87 transcriptomic data. This method allows us to infer not only the type of immune cells present in a 88 bulk tissue or blood but also the cytokine environment which they are likely encountering. We 89 have successfully identified 12 myeloid cell-cytokine stimulation signatures and correlated both 90
Mycobacterium tuberculosis infection status and glioma cancer outcome with these specific 91
signatures. 92
Source code for the CIBERSORT deconvolution algorithm, https://cibersort.stanford.edu/, was 142 obtained from the developers and implemented in the R statistical programming language (14) 143
All input bulk datasets were obtained as normalized count tables when available. If not 144 normalized datasets were scaled and quantile normalized according to the default CIBERSORT 145 functions. Our MCCS basis matrix was supplied as the average normalized expression level 146 across the three donors for our 131-gene set. The basis matrices for immunoStates (15) and 147 LM22 (1) were obtained from the respective publications. CIBERSORT was run according to 148 default parameters in all cases with 100 permutations. 149
150

M. tuberculosis sample collection and normalization 151
Conducting a literature search for all available TB infection studies with publicly available data 152 yielded 8 microarray and 5 RNA-Seq studies, with the following accession numbers; GSE19491, 153 GSE28623, GSE37250, GSE39939, GSE39940, GSE40553, GSE41055, GSE56153, 154 GSE101705, GSE107995, GSE79362, GSE89403, GSE94438 (16-28) . See Table S2 for 
7
RESULTS 186
Myeloid cells respond to cytokine stimulation with cell type specific transcriptional profiles. 187
In order to better understand how different human myeloid cells respond to activation by 188 different types of cytokines, we set out to compare the transcriptional profiles attained through 189 RNA-Seq of monocytes, neutrophils, macrophages and dendritic cells from the same healthy 190 donors in response to stimulation by type 1 cytokines (IFN-γ, IFN-β and IFN-), type 2 191 cytokines (IL-4 and IL-13) and the regulatory cytokine IL-10. Neutrophils and monocytes were 192 stimulated directly after isolation from blood leukopaks whereas macrophages and dendritic cells 193 were stimulated after a 4-day differentiation period from the isolated monocytes ( Fig. 1A) . RNA 194 was isolated 4 hours after stimulation for each of the four different cell types and stimulation 195 conditions including an unstimulated buffer control for each cell type. Donor to donor 196 differences had a much smaller effect on transcriptional profiles than differences between cell 197 types ( Fig. S1) . We next identified genes that were significantly upregulated in individual 198 cytokine stimulations relative to the unstimulated condition for each cell type. For example, with 199 macrophages, we identified a total set of 341 genes that were significantly upregulated, log2 fold 200 change greater than 2 and FDR less than 0.05, by at least one cytokine relative to the 201 unstimulated control samples. Monocytes upregulated 197 genes; dendritic cells upregulated 199 202 genes; and neutrophils were highly responsive and upregulated 274 genes in response to cytokine 203 stimulation ( Fig. 1C) . We then combined all of these lists for a total of 571 genes that are 204 upregulated by at least one cytokine in at least one myeloid cell type. Principle component 205 analysis (PCA) based on these genes indicated that each cell type engages a distinct 206 transcriptional programming for each cytokine stimulation ( Fig. 1B) . 35% of the explained 207 variation along the first principle component was strongly associated with cell type identity. 208
Within each myeloid cell type, it is clear that type 2 cytokines IL-4 and IL-13 triggered shared 209 transcriptional programs, whereas the type 1 cytokines IFN-β and IFN-γ triggered a similar set of 210 upregulated genes (Fig. 1C ). An IL-10 induced signature was observed in macrophages, 211 dendritic cells and monocytes but completely absent in neutrophils. Interestingly, neutrophils had 212 a robust response to other cytokines including a small subset of genes induced by IFN-, which 213
was not observed in the other cell types (Fig. 1C) . 214
With this set of 571 cytokine upregulated genes on myeloid cells, we considered if shared 215 8 Unsupervised clustering and correlation analysis of transcriptional responses showed a clear 217 distinction between stimulations of different cell types. Macrophages and dendritic cells had a 218 more closely correlated response while neutrophils and monocytes were more closely correlated 219 in their response signature ( Fig. 2A) . Although type 1 (especially IFN-γ and IFN-β) and type 2 220 (IL-4 and IL-13) cytokine specific responses mainly clustered together within each cell type, this 221
was not sufficient to override the correlation between cell type specific responses. These results 222 indicated that for the most part, the cell type is a larger determinant of whether a gene is 223 upregulated after stimulation than the cytokine. The only exception was a strong correlation 224 between macrophages and dendritic cells stimulated by IFN-β ( Fig. 2A) . 225
To obtain finer resolution on how the different cell types share responses to cytokine 226 stimulation, we looked for overlaps in differentially expressed genes between cell types. This 227 revealed that 81 of the 571 genes were upregulated in all four cell types (Fig. 2B) , which was 228 primarily driven by a shared response to IFN-β stimulation (Fig. 2C) . However, 342 of the other 229 upregulated genes were specific to a single cell type (Fig. 2B) , and further segregation by 230 cytokine stimulation confirmed that the major transcriptional response to each cytokine was 231 unique to a particular cell type ( Fig. 2C-H) . For example, IL-10 induced 47 genes that were 232 specific to monocytes, 9 to macrophages and 8 to dendritic cells while having almost no effect 233 on neutrophils ( Fig. 2H) . Alternatively, neutrophils induced 49 and 50 genes uniquely after IL-4 234 and IL-4 (cluster 4) and by IFN- (cluster 3) (Fig. 3A, B) . For macrophages, five clusters were 249 identified corresponding to genes upregulated by only IFN-β (cluster 2), both IFN-β and IFN-γ 250 (cluster 1), both IL-13 and IL-4 (cluster 5), IL-10 (cluster 3) and one cluster which could not be 251 clearly assigned (Fig. S2A, B) . In dendritic cells, four clusters were identified corresponding to 252 genes upregulated under IFN-β alone (cluster 1), IFN-β and IFN-γ combined (cluster 4), IL10 253 (cluster 2) and one cluster could not be assigned because two few genes were present (Fig. S2C,  254   D) . For monocytes, four clusters were identified corresponding to genes upregulated only by 255 IFN-β (cluster 1), both IFN-β and IFN-γ (cluster 3), IL-13 and IL-4 (cluster 4) and IL-10 (cluster 256
2) ( Fig. S2E, F) . Altogether, 12 cell type and stimulation specific expression patterns could be 257 identified by SOM analysis. Importantly, not all cell types and stimulation signatures were robust 258 enough to be clearly isolated. 259
Following identification of these 12 unique expression clusters, we performed outlier 260 analysis (13) to further filter the expression cluster gene list to only include genes highly specific 261 for the cell type and cytokine stimulation conditions identified by SOM analysis. Genes such as 262 RBBP6 and ASF1B were considered outliers for monocytes responding to IFN-β and IFN-γ and 263 neutrophils responding to IL-4 and IL-13 respectively (Fig. S3) , due to their highly specific and 264 consistent expression pattern in these cell type stimulation conditions across all three donors. 265
This evaluation identified 131 genes that reflected the 12 myeloid cell cytokine stimulation 266 conditions that were clearly distinguishable (Fig. 3C, S4 and Table S1 ). These genes represent a 267 high confidence marker gene set for myeloid cells under stimulation of various cytokines. We 268 refer to this as a myeloid cell cytokine specific (MCCS) signature. 269 270
Deconvolution of transcriptional signatures from M. tuberculosis Infection. 271
To determine the utility of our MCCS signature matrix, we first examined whole-blood 272 transcriptomes from 13 clinical cohorts infected with M. tuberculosis, which were publicly 273 available ( Table S2 ). Previous studies have described a neutrophil driven type 1 IFN-inducible 274 signature increased in patients with active disease compared to healthy and latently infected 275 individuals (16), hence we were interested in the role of neutrophil specific cytokine responses in 276 this context. More recently, circulating natural killer cells were also reported to increase in 277 abundance during tuberculosis latency but decreased back to baseline during active disease (33). 278
We compiled 8 available human whole blood microarray and 5 RNA-Seq datasets relevant to 279 active tuberculosis infections in GEO and analyzed the two sets independently. We focused our 280 analyses on the differences between healthy (microarray n = 88, RNA-Seq n = 365), latently 281 infected (microarray n = 376, RNA-Seq n = 117) and active disease individuals (microarray n = 282 547, RNA-Seq n = 306) as described in Table S2 . We first utilized the original LM22 basis 283 matrix from CIBERSORT (https://cibersort.stanford.edu)(1) and the more recent 'immunoStates' 284 matrix (15) to infer leukocyte representation by support vector regression through CIBERSORT. 285
The original LM22 basis matrix identifies 22 human hematopoietic cell phenotypes from 286 peripheral blood and in vitro culture conditions while immunoStates identifies 20 immune cell 287 types from over 6,000 samples during different disease states. Using these matrices, we were 288 able to confirm that CD56bright NK cells (immunoStates) were increased in abundance for 289 latently infected individuals both in the microarray and RNA-Seq datasets (Fig. 4A) . While the 290 signature of resting NK cells (LM22) also showed this response (Fig. S5E) in the microarray 291 dataset, the RNA-Seq dataset showed a slightly different pattern (Fig. S5F) . This finding is 292 consistent with immunoStates being an improved basis matrix compared to LM22 and confirmed 293 that our compiled datasets could reproduce previously published findings (33). 294
When we examined the inferred abundance of neutrophils, we found that the LM22 295 matrix indicated an increased abundance of neutrophils in actively infected individuals from the 296 microarray dataset (Fig. S5E) , but also suggested that neutrophils were more abundant in latently 297 infected individuals compared to healthy individuals from the RNA-Seq dataset (Fig. S5F) . In 298 contrast, the immunoStates matrix inferred greater abundance of neutrophils during active 299 disease from the RNA-Seq dataset (Fig. S5D) with decreased abundance of neutrophils during 300 latent infection in the microarray dataset (Fig. S5C) . When we applied our MCCS matrix on 301 these datasets, we found that there was a clear increase in actively infected individuals for 302 neutrophil response genes that were inducible by both IFN-γ and IFN-β (Fig. 4C) . Surprisingly, 303 genes that were only inducible by IFN-β in neutrophils were reduced in expression during active 304 infection compared to latent infection (Fig. 4B) . This was consistent for both microarray and 305
RNA-Seq datasets. Although a role for IFN-β during active tuberculosis infection has now been 306
well established (16), these results were surprising in that they point to a requirement for both 307 IFN-γ and IFN-β in driving the IFN-inducible signature of neutrophils during active 308 tuberculosis. Alternatively, it is perhaps impossible to truly determine if the IFN-inducible 309 signature of neutrophils is the result of type 1 or type 2 IFNs since they induce a similar set of 310 genes (34). Notably, when we examined other myeloid cell responses, we found that there was a 311 consistent reduction of the IL-4/IL-13 signatures from both monocytes ( Fig. 4D) and 312 macrophages (Fig. S5A,B) during active infection, relative to healthy and latently infected 313 individuals. Hence, in addition to providing further insights into the IFN-inducible neutrophil 314 signature during human tuberculosis, our MCCS matrix implicates a suppression of type-2 315 cytokine (IL-4 and IL-13) responses in monocytes and macrophages during active infection. 316
Additionally, there was an increased abundance of dendritic cells (DCs) expressing IFN-γ and 317 IFN-β inducible genes during active infection (Fig. S5A,B) . From these results, we were able to 318 gain additional biological insight into the cytokine responses of myeloid cells during different 319 stages of tuberculosis infection. 320 321
Interleukin-stimulated Neutrophil Signature Indicates Poor Survival in Glioma. 322
Recently, infiltrating and circulating myeloid cells have been tied to survival and likelihood of 323 response to immunotherapy in the context of human gliomas (35, 36) . A significant portion of 324 the cellular mass in primary glioma samples is infiltrating immune cells such as tumor-associated 325 macrophages (TAMs), whose levels correlate with tumor grade and severity, and other myeloid 326 subsets (37). Additionally, over 600 primary glioma tumors have been profiled by the Cancer 327 Genome Atlas (TCGA) (31) by a variety of sequencing methods including RNA-Seq with 328 detailed clinical outcome information. Applying statistical deconvolution based on our curated 329 MCCS signature, we found a strong but reciprocal relationship to survival for neutrophils 330 responding to IL-4 and IL-13 stimulation, and monocytes responding to IFN-β and IFN-γ 331 stimulation. Monocyte IFN responses were predictive of favorable survival, whereas tumors with 332 high neutrophil IL-4/IL-13 responses exhibited reduced patient survival ( Fig. 5A and S6) . 333
We next considered a more direct approach to assess the utility of our MCCS signature to 334 predict survival of patients with glioma. We trained least absolute shrinkage and selection 335 operator (LASSO) models on our 131-gene MCCS signature, the original LM22 (1) basis matrix 336 and the immunoStates (15) basis matrix separately to classify 2 and 5-year survival predictions. 337
Our model demonstrated robust survival prediction with an area under the ROC curve (AUC) 338 between 0.85 (5-year) and 0.89 (2-year) on our test set while the LM22 and immunoStates 339 signatures were lower (immunoStates AUC = 0.868 at 2 years and 0.763 at 5 years, LM22 AUC 12 = 0.828 at 2 years and 0.788 at 5 years) (Fig 5B and S7) . Evaluation of the gene importance for 341 survival predictions in our MCCS matrix at 5 years indicates that the top genes were derived 342 from the IL-4/IL-13-stimulated neutrophils and IFN-β and IFN-γ-stimulated monocytes (Fig.  343   5C) , confirming the CIBERSORT proportion estimates and survival curves shown in Figure 5A . 344
In addition to the cell type and stimulation condition we were also interested in the relationships 345 between the genes most predictive of long-term survival. Correlation analysis of the top features 346 with strong predictive power, as measured by feature importance (See methods) indicated two 347 distinct expression profiles (Fig 5D) . Furthermore, primary glioma samples from TCGA have 348 been previously profiled to identify somatic mutations and molecular markers (31) indicative of 349 survival. One such marker is the gene encoding isocitrate dehydrogenase (IDH), which when 350 mutated is known to be associated with increased patient survival in both low and high-grade 351 gliomas (38). Based on pairwise gene expression correlation analysis of the 40 most predictive 352 gene features from our model, we identified two clusters which were found to significantly differ 353 in their gene expression between glioma samples with a mutated or wild type IDH gene (Fig  354   5D ). Specifically, on average cluster 1 genes had higher expression in samples with wild type 355 IDH status while cluster 2 genes have significantly higher expression in samples with a mutated 356 IDH gene. This indicated that our set of genes were not only predictive of survival but also 357 strongly associated with known molecular markers for primary gliomas. 358
Given the strength of the importance measures for several of the top features we also 359 measured survival outcomes based on gene expression levels with a cox regression for ASF1B, 360 PLSCR1, SLC1A4 and GRIN3A and found significant associations between these expression-361 based models and survival (Fig. 5E ). ASF1B and PLSCR1 gene expression were indicative of 362 poorer survival outcomes while SLC1A4 and GRIN3A expression were indicative of more 363 favorable outcomes (Fig 5D, E) . Further, ASF1B, a strong indicator of glioma prognosis, was 364 derived from the neutrophil signature in response to IL-13 and IL-4 suggesting a more complex 365 role for neutrophils in the tumor microenvironment. Interestingly, expression of SLC1A4, 366 identified as part of the IL-4 and IL-13 stimulated macrophage signature, was indicative of better 367 survival (Fig 5E) In this study, we first assessed the transcriptional response of 4 different human myeloid cell 375 types to stimulation with a panel of cytokines. This enabled us to assemble a set of gene 376 signatures for myeloid cell type-cytokine specific response genes, which we could then assess 377 for biological and clinical relevance. Although limited to neutrophils, monocytes, macrophages 378 and dendritic cells currently, the signature matrix provides the cellular context these cells 379 experience during cytokine stimulation. This approach could be expanded to include additional 380 cell types as well as additional stimulation conditions to provide even more granular context. 381
Hence, controlled in-vitro assays could be quite relevant towards interpreting the expression 382 profiles in vivo for primary human blood and tissue samples. This approach can thus be applied 383 towards existing bulk transcriptomics data available in GEO, for example from GTeX and 384
TCGA. 385
In the context of M. tuberculosis infection the importance of an interferon-inducible gene 386 signature is well documented (39). The first seminal study, which also profiled purified cell 387 populations had indicated that this signature was driven by neutrophils and both IFN-γ and type 388 I interferon signaling (16). Our findings here are consistent with that initial report, since actively 389 infected individuals were enriched for neutrophil response genes that are inducible by both IFN-390 γ and IFN-β ( Fig. 4C) . However, we found that neutrophil genes inducible by IFN-β alone are 391 reduced in actively infected individuals indicating that IFN-γ may be more dominant than type 1 392 interferons in driving the interferon-inducible signature of neutrophils during active tuberculosis. 393 This is in contrast to a recent report showing that IFNG (which encodes IFN-γ) 394
and TBX21 (which encodes the transcription factor T-bet) are downregulated in patients with 395 active TB (17). Hence, the ratio of type 1 interferon vs IFN-γ inducible genes in neutrophils 396 needs to be better clarified in future studies. Since the goal of our study was to explore the 397 biological context of myeloid cells responding to cytokine stimulation, rather than to identify the 398 ideal gene signature for discriminating active TB from latent TB, we have not performed deeper 399 characterization of heterogeneity in the multiple datasets that we compiled from TB patients. 400
The relationship between neutrophil responses to IL-4 and IL-13 stimulation with glioma 401 survival was of particular interest. Previous reports from helminth infected mice have described a 402 distinct transcriptional response to type 2 cytokines in neutrophils (40) and the concept of N2 403 neutrophils in the tumor microenvironment has also been proposed (41, 42). However, the 404 transcriptional responses of human neutrophils to stimulation by IL-4 and IL-13 has not been 405 well established. Instead, TGF-β has been implicated in N2 polarization (43), which was not 406 examined as part of our analysis. Our results demonstrate not only that human neutrophils 407 respond to IL-4 and IL-13 stimulation with a very distinct transcriptional signature but also that 408 this signature can be detected in tumor samples and is associated with survival outcomes for 409 glioma in particular. Therefore, we provide some of the best evidence thus far that type-2 410 cytokine associated neutrophil activation may play an important role in tumor progression. 411
An important limitation of our study is that transcripts that were found to be associated 412 with specific myeloid cell type-cytokine stimulation combinations could also be expressed by 413 other immune or non-immune cells. While we are inferring or interpreting some of these results 414 in the context of myeloid cell responses, the same transcripts could be induced by other cell 415 types in response to other cytokines we have not examined. Future studies should expand upon 416 this preliminary assessment of 4 myeloid cell types and 6 cytokine combinations, to include 417 multiple immune and non-immune cell types and additional cytokines or other micro 418 environmental stimuli. Additionally, we have not assessed combinations of cytokines at varying 419 concentrations. In an inflamed environment, a combination of different cytokines at different 420 concentrations will have synergistic or inhibitory effects on different cell populations. 421
Recently, approaches have been developed to utilize single-cell transcriptomics data for 422 deconvolution of bulk transcriptomic data. While this approach could in principle assess 423 hundreds or thousands of cell states in bulk transcriptomic data, the reference collection sample 424 set for the scRNA-Seq profiles may not provide easily interpretable data on the cytokine 425 environment of the bulk tissue. We are currently working towards combining specific cytokine 426 stimulation conditions and scRNA-Seq to determine if we can assemble a cytokine specific 427 matrix for hundreds or thousands of single cell states. 428
We present here the concept of combining transcriptional profiles from in vitro 429 stimulated immune cells with different cytokines, together with algorithms such as CIBERSORT 430
(1) to infer the cytokine and immune cell environment within an inflamed tissue. We also 431 provide a myeloid cell cytokine signature matrix that can be used by the community to help 432 assess immune cell composition in complex samples. This approach has the potential to provide 433 additional biological insights into the ever-expanding collections of transcriptional profiling 434 datasets associated with different diseases, potentially leading to improvements in diagnosis and 435 therapeutic strategies during infection and tumor progression. 
